MARKET

FLDM

FLDM

Fluidigm
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.60
-0.24
-3.51%
After Hours: 6.60 0 0.00% 17:06 09/24 EDT
OPEN
6.75
PREV CLOSE
6.84
HIGH
6.82
LOW
6.60
VOLUME
414.90K
TURNOVER
--
52 WEEK HIGH
9.24
52 WEEK LOW
3.710
MARKET CAP
502.70M
P/E (TTM)
-8.2039
1D
5D
1M
3M
1Y
5Y
New COVID-19 testing mandate could strain already stretched supplies
A new six-point plan, announced by President Joe Biden on Thursday to fight the pandemic requiring COVID-19 vaccinations or regular testing for nearly two-thirds of U.S. employees could overwhelm the
Seekingalpha · 09/10 12:27
Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Chris Linthwaite, Presid...
GlobeNewswire · 09/02 12:30
Return on Capital Employed Insights for Fluidigm
After pulling data from Benzinga Pro it seems like during Q2, Fluidigm's (NASDAQ:FLDM) reported sales totaled $31.02 million. Despite a 10.62% in earnings, the company posted a loss of $17.27 million.
Benzinga · 08/31 15:27
BRIEF-CyTOF And Maxpar Direct Technologies Used In Study On Pregnant Women With SARS-CoV-2
reuters.com · 08/31 12:42
Fluidigm Highlights Publication Of New Data Further Validating Potential Of Its Mass Cytometry Technologies To Enable Deep Profiling Of Immune, Inflammatory Responses
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the publication of new data further validating the
Benzinga · 08/31 12:35
CyTOF and Maxpar Direct Technologies Utilized in Study Characterizing Immune and Inflammatory Responses in Pregnant Women Infected with SARS-CoV-2
Findings in Nature Communications Provide Insights That May Help Guide Patient Care Research Study Conducted in Collaboration with Fluidigm’s Therapeutic Insights Services SOUTH SAN FRANCISCO, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation ...
GlobeNewswire · 08/31 12:30
Needham Investment Management Llc Buys Fluidigm Corp, Frequency Electronics Inc, ACV Auctions ...
GuruFocus News · 08/17 19:38
Investors in Fluidigm (NASDAQ:FLDM) have unfortunately lost 25% over the last five years
While not a mind-blowing move, it is good to see that the Fluidigm Corporation ( NASDAQ:FLDM ) share price has gained...
Simply Wall St. · 08/10 06:19
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of FLDM. Analyze the recent business situations of Fluidigm through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average FLDM stock price target is 12.00 with a high estimate of 12.00 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 172
Institutional Holdings: 61.01M
% Owned: 80.10%
Shares Outstanding: 76.17M
TypeInstitutionsShares
Increased
29
6.46M
New
9
170.34K
Decreased
52
4.23M
Sold Out
33
4.09M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.19%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Non-Executive Chairman/Independent Director
Carlos Paya
President/Chief Executive Officer/Director
Stephen Linthwaite
Chief Financial Officer
Vikram Jog
Senior Vice President/General Counsel/Secretary
Nicholas Khadder
Senior Vice President
Bradley Kreger
Other
Colin Mccracken
Independent Director
Nicolas Barthelemy
Independent Director
Gerhard Burbach
Independent Director
Laura Clague
Independent Director
Bill Colston
Independent Director
Ana Stankovic
No Data
About FLDM
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.

Webull offers kinds of Fluidigm Corporation stock information, including NASDAQ:FLDM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLDM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FLDM stock methods without spending real money on the virtual paper trading platform.